Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Humana Inc (HUM) today and set a price target of $373. The company’s shares closed yesterday at $303.41.
Wiederhorn observed:
“HUM reported Q4:18 adj. EPS of $2.65 (GAAP: $2.58) vs. OPCO/Street estimates of $2.50/$2.53. Adj. results exclude a $0.17 gain on the KMG sale, offset by $0.13 for a Kindred-at-Home put/call adjustment and $0.11 amortization. According to HUM’s roll-forward, the beat was driven by Other/Misc (+ $0.09), offset by slight misses on HC-Services (-$0.15). Management discussed lower inpatient utilization, partially offset by higher Retail outpatient spending. Post-quarter, Humana issued FY2019 adj. EPS guidance of $17.00-$17.50 vs. OPCO/Street’s $17.41/$17.47E, consistent with prior comments that guidance would meet consensus entering Q3 earnings ($17.18). As discussed below, the Retail outlook appears to be the largest driver of the implied 17-20% EPS growth. Last, the company raised the quarterly dividend 10% to $0.55/shr.”
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 15.4% and a 68.8% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Centene Corp, UnitedHealth, and Cigna Corp.
Currently, the analyst consensus on Humana Inc is a Strong Buy with an average price target of $376.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $355.88 and a one-year low of $260. Currently, Humana Inc has an average volume of 1.13M.
Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. Most recently, in November 2018, Timothy Huval, the Chief HR Officer of HUM sold 5,165 shares for a total of $1,777,845.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Humana Inc. is a health and well-being company focused on making it easy for people to achieve best health. Its strategy integrates care delivery, the member experience, and clinical & consumer insights to encourage engagement, behavior change, proactive clinical outreach, and wellness for the people.
